0

WHY THIS MATTERS IN BRIEF

When some animals loose a limb they can regrow them, and slowly we’re unlocking the secrets of mammalian regeneration.

 

Interested in the future and want to experience even more?! eXplore More.

Recently teams in the US managed unlock the regenerative secrets of Zebra fish, re-activate the genes for whole body regeneration, and regrow severed frogs legs after they treated the frogs with what they called a silk bioreactor – essentially a cocktail of hormones and progesterone wrapped in a silk scarf. All world firsts.

 

RELATED
Researchers have discovered how to build self-healing fusion reactors

 

And now in a new breakthrough in regenerative medicine researchers have discovered a pair of proteins that one day could help people regenerate limbs in much the same way that starfish and other animals do. When applied to amputated toes, the proteins encouraged both bone and joint growth in mice, but joints are structurally complex, so even for animals that can regrow their lost limbs they often struggle to regenerate their joints as well. However, in this case that’s exactly what happened and this makes the latest discovery remarkable.

Ken Muneoka at Texas A&M University in the US and his colleagues had previously regenerated bones in mice after they were amputated by treating the stump with a bone-growing protein, BMP2. But the joint structures never formed, and the team suspected that another bone growing protein, BMP9, could be essential in joint building. So they tried applying the protein to mice that had their toes amputated. After three days, over 60 per cent of the stump bones formed a layer of cartilage, as seen in joints, at the end of the bones.

 

RELATED
New 3D graphene is as light as air and ten times stronger than steel

 

The result was more effective when the team treated the wounds first with BMP2 and then BMP9 a week later. Not only did the bones regrow they also formed more complete joint structures with part of the new bones attached to them. Although the method doesn’t yet produce a full toe. But one day…

“Our study is transformational,” says Muneoka. He suggests this experiment proves that even though mammals can’t regenerate body parts, we have cells that know how to and what to grow.

 

RELATED
US Pentagon surrenders and admits it can no longer keep pace with cyber attacks

 

“They can do it, they just don’t do it. So, we have to figure out what’s constraining them,” he says.

Because human skeletal structure is very similar to that of mouse, Muneoka says he is optimistic that one day we will be able to help amputees regrow their limbs. But many more studies need to be done before any trials in humans, he says.

Journal reference: Nature Communications, DOI: 10.1038/s41467-018-08278-4

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the World Futures Forum and the 311 Institute, a global Futures and Deep Futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future” series. Regularly featured in the global media, including AP, BBC, CNBC, Discovery, RT, and Viacom, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Bain & Co, BCG, Credit Suisse, Dell EMC, Dentons, Deloitte, E&Y, GEMS, Huawei, JPMorgan Chase, KPMG, Lego, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, T-Mobile, and many more.

Comments

Your email address will not be published. Required fields are marked *